What is the prevalence of Haemophilia?

Haemophilia is a rare, lifelong genetic bleeding disorder that affects approximately 1 in 10,000 individuals worldwide, with Haemophilia A being the most common form. While Haemophilia primarily affects males due to its X-linked inheritance pattern, the condition is considered a rare disease, though true prevalence is likely higher than current registries suggest due to underdiagnosis in many regions.

What is the global prevalence and incidence of Haemophilia?

The global prevalence of Haemophilia is estimated at approximately 1,125,000 cases worldwide according to the World Federation of Hemophilia (WFH). Specifically, Haemophilia A occurs in about 1 in 5,000 male births, while Haemophilia B is rarer, affecting approximately 1 in 25,000 to 30,000 male births. Because Haemophilia is a chronic genetic condition, these prevalence figures represent the total number of individuals living with the disorder, rather than just new cases. Incidence rates are relatively stable, as the condition is present from birth, though it is often diagnosed in early childhood when physical activity increases or during surgical procedures.

How does gender and genetics influence Haemophilia distribution?

Haemophilia is caused by mutations in the F8 gene (Haemophilia A) or F9 gene (Haemophilia B), both located on the X chromosome. Because males have only one X chromosome, they are almost exclusively the ones who manifest the symptoms of Haemophilia. Females are typically carriers, though they may experience mild bleeding symptoms due to skewed X-inactivation. It is important to note that while Haemophilia is hereditary, approximately 30% of new cases occur due to spontaneous mutations in families with no prior history of the disorder.

Are there challenges in tracking the true prevalence of Haemophilia?

Accurate epidemiological data for Haemophilia remains difficult to capture for several reasons. The following factors contribute to the gap between estimated and reported cases:

• Underdiagnosis: In developing nations, individuals with mild forms of Haemophilia may go undiagnosed for their entire lives, only seeking medical attention after significant trauma or surgery.


• Geographic Variability: Access to genetic testing and specialized coagulation centers varies significantly, leading to lower reported prevalence in regions with limited healthcare infrastructure.


• Diagnostic Complexity: Misdiagnosis can occur, particularly when bleeding symptoms are confused with other platelet disorders or von Willebrand disease.


• Community Insights: At DiseaseMaps.org, 334 people with Haemophilia have joined our community to share their lived experiences, providing a crucial real-world perspective that often highlights the diagnostic delays and challenges not always captured in clinical registries.

Is Haemophilia considered a common or rare disease?

Haemophilia is classified as a rare disease by international health organizations, including the NIH Genetic and Rare Diseases Information Center (GARD). While it is one of the most widely recognized rare conditions, its rarity is defined by the relatively low number of people affected in the total population. Despite this, the medical community has made significant strides in treatment, moving from supportive care to prophylactic factor replacement therapy and emerging gene therapies, which continue to improve the quality of life for those living with the condition.

Next steps

• Consult a hematologist specializing in bleeding disorders to discuss your specific genetic profile and care plan.


• Connect with the 334 members on DiseaseMaps.org to share experiences and find support within the Haemophilia community.


• Register with national or regional Haemophilia foundations to stay informed about the latest clinical trials and therapeutic advancements.


• If you suspect a family history, seek genetic counseling to understand the inheritance risks for future generations.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider.

References

• World Federation of Hemophilia (WFH) - Annual Global Survey on Bleeding Disorders.


• NIH Genetic and Rare Diseases Information Center (GARD) - Haemophilia Overview.


• Orphanet - Rare Disease Database (ORPHA:399).


• OMIM (Online Mendelian Inheritance in Man) - Haemophilia A (#306700) and B (#306900).